NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Arda Therapeutics

Arda Therapeutics

Private
San Carlos, CaliforniaHealthcare & Life Scienceswww.ardatx.com

Last Round

Seed Round

Jun 3, 2026

Total Funding Raised

$50.5M

Momentum Score

25 /100

Company Overview

Arda Therapeutics is a biotechnology company that develops transformative therapeutics aimed at eliminating pathological cells responsible for chronic diseases by utilizing single-cell data to precisely target and remove these harmful cells without impacting healthy tissue.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

targeted cell depletionantibody-drug conjugatesADCsdrug discovery platformtargeted biologicsAI drug discoverysingle-cell analysisfibrosis treatmentbiotechnology platformchronic disease therapieslongevity biotechprecision medicineautoimmune disease treatmentmetabolic disorder treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arda Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arda Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 3, 2026
Series AOct 9, 2024
SeedJan 25, 2022

Key People

Founding team and executive leadership

Remi-Martin Laberge

Co-Founder, CTO

Founding Team

Adam Freund

Founder And CEO

Founding Team

Arda Therapeutics Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries A, Seed
LifeLink VenturesSeries A
GVSeries A, Seed
Global VillageSeed
GaingelsSeries A
Mana VenturesSeries A
Valhalla VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    $50K Seed Round raised.

Arda Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arda Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arda Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range18
Year Founded2021
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.